June Monthly Lecture: Re-thinking HIV Prevention with Pre-exposure Prophylaxis

By Pharmaceutical Society of Australia

Date and time

Tue, 6 Jun 2017 7:30 PM - 9:00 PM AEST

Location

Victoria Australia

Description

How we prevent and manage HIV has come a long way since its discovery over 30 years ago. HIV medicine has advanced to the point where the elimination of all HIV transmission is achievable in the short-term and has been implemented as a key strategic goal by a number of Australian state governments.

Critical to this success is the population-based, targeted roll-out of HIV PrEP. PrEP involves taking one pill daily of tenofovir disoproxil fumarate (TDF)/ emtricitabine (FTC), available in Australia as Truvada. TDF/FTC has been extensively used in millions of people with HIV for about 15 years, and with international data suggesting a 99% reduction in risk of contracting HIV when used daily in HIV negative people, the introduction of PrEP is redefining our thoughts and beliefs around safer sex practices.

To help achieve this goal, it is paramount that community, hospital and consultant pharmacists have the confidence, skills and knowledge to provide comprehensive care when managing patients using PrEP or requesting information about its indication and availability.

At the end of this session, you will be able to:

1. Describe the pharmacology of nucleoside reverse transcriptase inhibitors (NRTIs)

2. Explain NRTIs therapeutic use and efficacy in HIV prevention when used as PrEP

3. Summarise the key results from PrEP studies

4. Recognise the importance of educating and managing patients using PrEP or those wanting to access information about PrEP

Competency Standards:1.3.2, 1.4.2, 4.2.1, 4.2.2, 4.2.3, 4.3.3, 6.1.1, 6.1.3, 6.2.2, 6.3.1, 6.3.2, 6.3.3, 8.1.3, 8.2.3.

Correct at the time of publication and subject to change

**Networking and refreshments from 7pm**

Supported by Gilead. Gilead has had no input into the content of the materials and presentation used at this event.

This event is supported by an unrestricted educational grant from PDL

This event will be broadcast live from NSW

Non Member Price $75.00 - Please contact PSA Victorian Office if you are not a PSA Member and wish to attend (9389 4000)

Organised by

PSA proudly represents Australia’s 29,000 pharmacists working in all sectors and locationsand is committed to improving our nation’s health through excellence in pharmacist care.

The Federal Government has awarded the Pharmaceutical Society of Australia (PSA) withnational peak health body status, recognising our role in advising Government on policy,provision of pharmacist education and representation of pharmacists.

Sales Ended